Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000247345

Medchemexpress LLC N-(cyanomethyl)-N-methyl-2-oxo-2-[4-(7-oxo-6,7,8,9-tetrahydro-5H-benzoannulen-5-yl)phenoxy] | 2226521-65-7 | MFCD31630713 | 99.6% | 428.49 g·mol⁻1 | C24H24N6O2 | 50 MG
SDP

Catalog No. 5000247345
Encompass_Preferred

FM-381 is a potent, covalent reversible inhibitor selective for Janus kinase 3 (JAK3). It demonstrates sub-nanomolar potency (IC50 = 127 pM) and high selectivity versus other JAK family members, making it a useful research tool for probing JAK/STAT signaling in biochemical and cellular studies. Supplied as a high-purity material for laboratory use.

  • High potency for JAK3 (IC50 = 127 pM).
  • Covalent reversible mode of inhibition.
  • Marked selectivity versus JAK1, JAK2, and TYK2.
  • Suitable for biochemical and cellular assays.
  • Provided as a high-purity research chemical.

Catalog No. 50-002-47345 Supplier Medchemexpress LLC Supplier No. HY10204650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

FM-381 is a potent, covalent reversible inhibitor selective for Janus kinase 3 (JAK3). It demonstrates sub-nanomolar potency (IC50 = 127 pM) and high selectivity versus other JAK family members, making it a useful research tool for probing JAK/STAT signaling in biochemical and cellular studies. Supplied as a high-purity material for laboratory use.

  • High potency for JAK3 (IC50 = 127 pM).
  • Covalent reversible mode of inhibition.
  • Marked selectivity versus JAK1, JAK2, and TYK2.
  • Suitable for biochemical and cellular assays.
  • Provided as a high-purity research chemical.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.